2024-11-24 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**1. Performance Comparison & Divergence:**

UnitedHealth Group Inc. (UNH) significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for UNH is 201.96%, while VOO's is 127.58%. This represents a difference of 74.38%, placing it at the 46.97th percentile of its historical performance relative to the S&P 500.  UNH's outperformance is substantial.

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health insurance and healthcare services.

**Alpha & Beta Analysis:** The provided data shows consistent positive alpha (outperformance relative to the market) across most periods, especially between 2015 and 2019.  The beta, generally around 0.9, indicates moderate sensitivity to market fluctuations, though this decreased to 0.5 in the most recent two years.  Market capitalization (Cap(B)) shows substantial growth over the period.

**2. Recent Price Movement:**

* **Closing Price:** $590.78 (Last-market: $590.73)
* **5-Day Moving Average:** $591.08
* **20-Day Moving Average:** $587.59
* **60-Day Moving Average:** $584.33

The price is slightly below the 5-day moving average, suggesting a minor short-term downtrend. However, it's above both the 20-day and 60-day moving averages, indicating a positive longer-term trend.

**3. Technical Indicators & Relative Divergence:**

* **RSI (Relative Strength Index):** 61.08. This suggests the stock is neither overbought nor oversold, remaining in neutral territory.
* **PPO (Price Oscillator):** -0.07. A negative value suggests bearish momentum.
* **Delta_Previous_Relative_Divergence:** +4.11. This indicates a recent increase in relative strength compared to the S&P 500.
* **Expected Return:** 36.54%. This is a significant projected outperformance compared to the S&P 500 over the long term (2+ years) if invested consistently.

The closing price of $590.73 does not show any signs of a significant recent spike (upward or downward).  There is no evidence of rapid price movement either up or down.


**4. Recent Earnings & Outlook:**

The provided earnings data shows some volatility in EPS (earnings per share). There was a negative EPS in Q2 2024, which is unusual,  requiring further investigation.  Revenue has been consistently high, with a slight dip in Q4 2023.  The most recent EPS (6.56 for the quarter ending 2024-11-04) needs further context, ideally comparing it with analyst expectations to assess whether the results beat or missed forecasts.


**5. Financial Information:**

* **Revenue & Profitability:** Revenue remains robust, showing some quarter-to-quarter variation, but overall trending upward.  Profit margins appear strong, though some fluctuation is observable.
* **Capital & Profitability:** Equity has grown, but ROE (Return on Equity) has fluctuated, even showing a negative value in one quarter (2024-03-31). This deserves deeper analysis to determine the underlying causes.

**6. News & Recent Issues:**

*(This section requires access to real-time news sources such as Shacknews, FINBOLD, etc.  I cannot provide this information directly as I don't have access to live news feeds.)*  Please consult recent news articles about UNH for up-to-date information on earnings announcements, analyst opinions, and market outlook.


**7. Summary & Synthesis:**

UNH has significantly outperformed the S&P 500 over the long term, demonstrating strong growth and generally positive alpha.  While recent technical indicators provide a mixed signal (RSI neutral, PPO slightly negative), the long-term outlook, supported by the expected return, appears positive.  However, the recent negative EPS and fluctuating ROE warrant careful scrutiny. Analysis of the most recent earnings report against analyst expectations and a detailed review of the reasons for the negative ROE are crucial for a comprehensive assessment.  News sources should be consulted for up-to-date market sentiment and any significant recent events impacting UNH.


**8. Conclusion:**

UnitedHealth Group (UNH) shows a history of strong performance relative to the market. The long-term outlook seems positive, but a more in-depth analysis of recent financial statements and news is needed before making any investment decisions. Pay particular attention to the Q2 2024 negative EPS and the fluctuating ROE to understand the underlying drivers.


**(Note: This report is based solely on the provided data.  Independent research and verification are highly recommended before making any investment decisions.)**
